[
  {
    "ts": null,
    "headline": "What Is One of the Best Healthcare Stocks to Own for the Next 10 Years?",
    "summary": "Don't let current struggles distract from this company's long-term appeal.",
    "url": "https://finnhub.io/api/news?id=771e2d279fa3627dfa5518dcb0c1a94bcdfbf46d83271bff62d89e29ed9ed906",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771445100,
      "headline": "What Is One of the Best Healthcare Stocks to Own for the Next 10 Years?",
      "id": 139139339,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Don't let current struggles distract from this company's long-term appeal.",
      "url": "https://finnhub.io/api/news?id=771e2d279fa3627dfa5518dcb0c1a94bcdfbf46d83271bff62d89e29ed9ed906"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Faces New Challenges -- What Investors Need to Know",
    "summary": "A potential new challenge could weigh on profit.",
    "url": "https://finnhub.io/api/news?id=76f544b250c55a9ca0f7758eed221c00dc1adb0fa96b4e0b0d9f7c164a9c9ec9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771432500,
      "headline": "UnitedHealth Group Faces New Challenges -- What Investors Need to Know",
      "id": 139137865,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "A potential new challenge could weigh on profit.",
      "url": "https://finnhub.io/api/news?id=76f544b250c55a9ca0f7758eed221c00dc1adb0fa96b4e0b0d9f7c164a9c9ec9"
    }
  },
  {
    "ts": null,
    "headline": "Is a Dividend Cut Coming for UnitedHealth Stock?",
    "summary": "Investors shouldn't have to worry about at least one thing with this giant health insurer.",
    "url": "https://finnhub.io/api/news?id=b2a5a91178e9962fa3fe0f7c74cece2e88ccbd2af483f2949871f08e73314b8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771413000,
      "headline": "Is a Dividend Cut Coming for UnitedHealth Stock?",
      "id": 139132558,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Investors shouldn't have to worry about at least one thing with this giant health insurer.",
      "url": "https://finnhub.io/api/news?id=b2a5a91178e9962fa3fe0f7c74cece2e88ccbd2af483f2949871f08e73314b8c"
    }
  },
  {
    "ts": null,
    "headline": "XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500",
    "summary": "Healthcare isn’t going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions. Health Care Select Sector SPDR Fund (NYSEARCA:XLV) offers concentrated exposure to this defensive sector, but with concentration comes tradeoffs investors must understand before allocating capital. Pure Healthcare Exposure With Mega-Cap Anchors XLV functions ... XLV is A $41 Billion Defensive Healthcare Play That Looks",
    "url": "https://finnhub.io/api/news?id=d88d9891829ddb340cf72a3b311e050a1ba7b49790128751ab2509b9b5f4faf7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771410775,
      "headline": "XLV is A $41 Billion Defensive Healthcare Play That Looks Good Until You Compare To The S&P 500",
      "id": 139132609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "Healthcare isn’t going anywhere. An aging population, chronic disease management, and breakthrough treatments ensure this sector remains essential regardless of market conditions. Health Care Select Sector SPDR Fund (NYSEARCA:XLV) offers concentrated exposure to this defensive sector, but with concentration comes tradeoffs investors must understand before allocating capital. Pure Healthcare Exposure With Mega-Cap Anchors XLV functions ... XLV is A $41 Billion Defensive Healthcare Play That Looks",
      "url": "https://finnhub.io/api/news?id=d88d9891829ddb340cf72a3b311e050a1ba7b49790128751ab2509b9b5f4faf7"
    }
  },
  {
    "ts": null,
    "headline": "IXJ: Healthcare Sector Dashboard For February",
    "summary": "IXJ: Healthcare Sector Dashboard For February",
    "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771408800,
      "headline": "IXJ: Healthcare Sector Dashboard For February",
      "id": 139136343,
      "image": "",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=4c7217c375ec3588b7d733d67e76ed36acfbee5d367368b6809a501d5b536ff7"
    }
  },
  {
    "ts": null,
    "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
    "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year.",
    "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771404877,
      "headline": "FDA chief Marty Makary says 'everything should be over the counter' unless drug is unsafe or addictive",
      "id": 139137337,
      "image": "https://image.cnbcfm.com/api/v1/image/108111981-17412749682025-03-06t152858z_1041948067_rc2r7da7wjpm_rtrmadp_0_usa-trump-fda.jpeg?v=1741274989&w=1920&h=1080",
      "related": "UNH",
      "source": "CNBC",
      "summary": "Makary said the FDA is looking at prescription drugs like nausea medications and vaginal estrogen, and hopes to make changes this year. ",
      "url": "https://finnhub.io/api/news?id=04105639750ceec82f927ba72ef6ce83266b0d6af2f1fef117a869390c1457e0"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth: Compelling Value Proposition, But Risks Greatly Elevated",
    "summary": "UnitedHealth: Compelling Value Proposition, But Risks Greatly Elevated",
    "url": "https://finnhub.io/api/news?id=a7630988c62714ed900a4747add28f980f1cb817f3a5a7bf25bff0b8b1146bba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771380000,
      "headline": "UnitedHealth: Compelling Value Proposition, But Risks Greatly Elevated",
      "id": 139130394,
      "image": "",
      "related": "UNH",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a7630988c62714ed900a4747add28f980f1cb817f3a5a7bf25bff0b8b1146bba"
    }
  },
  {
    "ts": null,
    "headline": "UnitedHealth Group Turbulent Year Tests Outlook For 2026 Rebound",
    "summary": "UnitedHealth Group, NYSE:UNH, is coming off a year of elevated healthcare costs, a major cybersecurity breach, antitrust litigation, and questions over health claims practices. The company has outlined expectations for a rebound in 2026 after this challenging stretch. Separate scrutiny has emerged over former CEO Stephen Hemsley's investment activity through affiliates, which critics say may pose conflicts of interest. UnitedHealth states that these investments comply with its corporate...",
    "url": "https://finnhub.io/api/news?id=84b693a1a5ffb57053ec7b162e46594f003bab75e204a630e7e5527b8f828490",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771373966,
      "headline": "UnitedHealth Group Turbulent Year Tests Outlook For 2026 Rebound",
      "id": 139128222,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "UNH",
      "source": "Yahoo",
      "summary": "UnitedHealth Group, NYSE:UNH, is coming off a year of elevated healthcare costs, a major cybersecurity breach, antitrust litigation, and questions over health claims practices. The company has outlined expectations for a rebound in 2026 after this challenging stretch. Separate scrutiny has emerged over former CEO Stephen Hemsley's investment activity through affiliates, which critics say may pose conflicts of interest. UnitedHealth states that these investments comply with its corporate...",
      "url": "https://finnhub.io/api/news?id=84b693a1a5ffb57053ec7b162e46594f003bab75e204a630e7e5527b8f828490"
    }
  }
]